About Gene List

PF3D7_1431500 (MAPK1)

Genome location: Pf3D7_14_v3:1,238,794..1,242,545(-)

Genome classification: Core

Function and Localization

Product Description: mitogen-activated protein kinase 1

SignalP Peptide: N/A

# Transmembrane Domains: 0

EC Numbers: 2.7.11.24 (Mitogen-activated protein kinase)

Curated GO (PlasmoDB):

Type GO Term Name
Component GO:0005737 cytoplasm
Component GO:0005634 nucleus
Function GO:0004707 MAP kinase activity
Process GO:0035556 intracellular signal transduction
Process GO:0006468 protein phosphorylation
Process GO:0010468 regulation of gene expression

Expression by stage (LR - Le Roch et al., and MCA - Malaria Cell Atlas):

Stage LR class MCA mean MCA prop. zeros
Sporozoite expressed N/A N/A
Ring possibly expressed 0.13 0.94
Trophozoite expressed 0.62 0.64
Schizont expressed 0.38 0.77
Gametocyte expressed 0.72 0.62

More info:

Resistome Mutations

Old (Pf3D7v3) Gene ID: PF3D7_1431500

Resistome Missense Mutations: None

Resistome Compounds with Missense Mutations: None

Resistome # Samples with Disruptive Mutations: 0 (0 missense, 0 "interesting" missense)

Essentiality (ABS)

Zhang Phenotype: Mutable in CDS

MIS: 1 | MFS: -2.499 | #Insertions: 1

PlasmoGEM Phenotype: Dispensable (Pb ortholog: PBANKA_1013300)

  • Relative Growth Rate: 1.01 ± 0.03
  • Confidence: 8.54

RMgmDB ABS Phenotype: Not different from wild type (Pb ortholog: PBANKA_1013300)

Modification: Disrupted | RMgm-4551

More info: PhenoPlasm Link

Binding Evidence

AlphaFill Uniprot ID: Q8ILF0

"Best" AlphaFill ligand hit: I46 (2-fluoro-4-[4-(4-fluorophenyl)-1h-pyrazol-3-yl]pyridine, Local RMSD=1.00) with 3K3I (Global RMSD=2.53)

BRENDA EC Inhibitors:

EC # Name EC Inhibitors
2.7.11.24 mitogen-activated protein kinase ADPH89MKK4MKP3MG132U0126SB202VX745siRNAML3403SR3451SR3582...

Orthology to BindingDB Entries:

UniProt Protein Name Species Homology Source BindingDB Ligands
Q8TD08 Mitogen-activated protein kinase 15 Homo sapiens OrthoDB, OrthoMCL BLAST CHEMBL1234833Staurosporine, 8CHEMBL2430323CHEMBL4075720...

Orthology Information

Ortholog Group (OrthoMCL): OG6_102994

Most Similar Human Ortholog: A0A1C7CYZ1

TM-align score: 0.87 | RMSD: 1.66

Seq Identity: 0.49 | Length: 256 / 914

All Human Orthologs (OrthoMCL):

Gene ID Description
ENSG00000181085 mitogen-activated protein kinase 15
ENSG00000274205 mitogen-activated protein kinase 15

Protein Information

Protein Length: 914 | Molecular Weight (kDa): 107.277

UniProt ID(s): Q25758, Q8ILF0, Q94656

PDB ID(s): None

Isoelectric Point: 9.88

Protein Domain Annotations:

Source Family ID Description
InterPro IPR000719 Protein kinase domain
InterPro IPR003527 Mitogen-activated protein (MAP) kinase, conserved site
InterPro IPR008271 Serine/threonine-protein kinase, active site
InterPro IPR011009 Protein kinase-like domain superfamily
InterPro IPR017441 Protein kinase, ATP binding site
PFam PF00069 Protein kinase domain
Superfamily SSF56112 Protein kinase-like domain superfamily
Superfamily SSF69349

Genetic Variation

MalariaGEN Pf7 (worldwide samples) # unique SNV/indels:

Homozygous genotype calls only

variant type common rare doubleton singleton
synonymous 4 44 34 41
disruptive 24 77 45 137
missense 12 65 39 111

Any inclusion in genotype call

variant type common rare doubleton singleton
synonymous 10 80 38 57
disruptive 43 174 83 195
missense 21 136 70 123

PlasmoDB Total SNPs: 178

Non-coding: 72 | Synonymous: 74 | Nonsynonymous: 32 | Stop Codon: 0

Associated Publications

PMID Title Authors DOI/Link
9004228 Characterization of a mitogen-activated protein (MAP) kinase from Plasmodiumfalciparum. Graeser R, Kury P, Franklin RM, Kappes B 10.1046/j.1365-2958.1997.2071571.x
12368864 Genome sequence of the human malaria parasite Plasmodium falciparum. Gardner MJ, Hall N, ..., Barrell B 10.1038/nature01097
16267556 A protein interaction network of the malaria parasite Plasmodium falciparum. LaCount DJ, Vignali M, ..., Hughes RE 10.1038/nature04104
23544094 Plasmodium berghei MAPK1 displays differential and dynamic subcellularlocalizations during liver stage development. Wierk JK, Langbehn A, ..., Deschermeier C 10.1371/journal.pone.0059755